Abstract
The ability of several 4- and 5-ring polycyclic aromatic hydrocarbons (PAHs), heterocyclic PAHs, and their monohydroxy derivatives to interact with the estrogen receptor (ER) alpha and beta isoforms was examined. Only compounds possessing a hydroxyl group were able to compete with 3H-labeled 17β-estradiol (E2) for binding to either a glutathione-S-transferase and human ERα D, E, and F domain fusion protein (GST-hERαdef) or to the full-length human ERβ. Competitive binding was comparable for both isoforms, with IC50 values ranging from 20 to 300 nM (E2 IC50 approximately 3 nM). However, several compounds were able to induce reporter gene expression preferentially through mERβ, using MCF-7 cells transiently transfected with either a Gal4-human ERαdef or Gal4-mouse ERβdef construct, as well as a Gal4-regulated reporter. These data extend the number and type of PAH-related compounds capable of interacting with ERα and ERβ, and provides additional evidence that even though some compounds may possess a similar affinity for both ER isoforms, the capacity for transcriptional activation can still be isoform-specific.
| Original language | English |
|---|---|
| Pages (from-to) | 167-177 |
| Number of pages | 11 |
| Journal | Toxicology Letters |
| Volume | 121 |
| Issue number | 3 |
| DOIs | |
| State | Published - May 19 2001 |
Keywords
- Estrogen receptor
- Estrogenic endocrine disruptor
- Heterocyclic PAHs
- Monohydroxy PAHs
- PAHs
Fingerprint
Dive into the research topics of 'Interaction of PAH-related compounds with the α and β isoforms of the estrogen receptor'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver